Boehringer Ingelheim Korea severs ties with Daewoong

Boehringer Ingelheim Korea severed its strategic ties with Daewoong Pharmaceutical over the co-promotion of latter’s over-the-counter (OTC) medicines, it was learned yesterday.

Though the reasons for their sudden severance were not elaborate, industry observers said that the Boehringer Ingelheim Korea side has so far pressed Daewoong to achieve bigger sales, while Daewoong has untaken heavy ...